Visual analysis of solid tissue mounted on glass slides is currently the 27 primary method used by pathologists for determining the stage, type and 28 subtypes of cancer. Although whole slide images are usually large (10s to 29 100s thousands pixels wide), an exhaustive though time-consuming 30 assessment is necessary to reduce the risk of misdiagnosis. In an effort to 31 address the many diagnostic challenges faced by trained experts, recent 32 research has been focused on developing automatic prediction systems for 33 this multi-class classification problem. Typically, complex convolutional 34 neural network (CNN) architectures, such as Google's Inception, are used to 35 tackle this problem. Here, we introduce a greatly simplified CNN 36 architecture, PathCNN, which allows for more efficient use of computational 37 resources and better classification performance. Using this improved 38 architecture, we trained simultaneously on whole-slide images from multiple 39 tumor sites and corresponding non-neoplastic tissue. Dimensionality 40 reduction analysis of the weights of the last layer of the network capture 41 groups of images that faithfully represent the different types of cancer, 42 highlighting at the same time differences in staining and capturing outliers, 43 artifacts and misclassification errors. Our code is available online at: 44 https://github.com/sedab/PathCNN. 45 46 47
Introduction 48
Examination of hematoxylin & Eosin (H&E) images of surgical resections or 49 tissue biopsies by pathologists is often the first step in identifying and 50 characterizing a tumor. Given the size of such images (from tens to 51 hundreds of thousands of pixels wide), the complexity and heterogeneity of 52 neoplastic and non-neoplastic pathology, this task is non-trivial with some 53 risk to miss small tumor foci or misclassifying minor variants or features 54 present in the image. The benefit of distinguishing non-neoplastic conditions 55 from neoplastic tissue is obvious, but quickly and accurately differentiating 56 between subtypes can also be critical for initiating targeted therapies [1] . 57
For example, in the case of lung cancer, the efficacy of conventional 58 chemotherapies differs for the two major subtypes of non-small cell lung 59 cancer (NSCLC), squamous cell carcinoma and adenocarcinoma. Certain 60 agents may be less efficient [2] or more invasive for patients presenting 61 squamous cell carcinoma [3] . On the other hand, adenocarcinoma is more 62 likely to contain genetic mutations which may be treated with targeted 63 therapy, such as EGFR mutations or ALK rearrangements [4] . Although 64 neoplastic subtypes are often visually distinct, diagnostic agreement for 65 classifying adenocarcinomas and squamous cell carcinomas of the lung has 66 been found to be relatively low (κ = 0.41 -0.46 among community 67 pathologists, κ = 0.64 -0.69 among pulmonary pathology experts and κ = 68 0.55 -0.59 among all pathologists under study) [5] . The difference between 69 community pathologists and pulmonary pathology experts suggests that 70 automated technology may aid the diagnostic process in areas lacking 71 specialized expertise. Furthermore, most pathologists follow simple 72 algorithmic decision tree approaches that use only limited amounts of 73 information presented in these images [6] . For the same task on lung 74 cancer, Yu et. al [7] used an automatic image-segmentation pipeline to 75 identify the tumor nuclei and tumor cytoplasm from which they extracted 76 image features. Several classical machine learning approaches have been 77 developed to achieve classification of lung [8, 9] and breast [10, 11] cancers. 78
Advances in deep learning have paved the way for artificial neural networks 79 to surpass most traditional machine learning methods in the field of image 80 processing. In particular, convolutional neural networks (CNNs) consists of 81 convolutional layers which exploit locality and stationarity and were first 82 proposed by Le Cun et al. [12] These approaches have quickly risen to the 83 state-of the-art on almost all image-based tasks including medical imaging 84 [13, 14] . One of the benefits of using a convolutional neural network 85 architecture is that using domain knowledge to handcraft an image feature 86 extraction system is not required. Conveniently, feature extraction is an 87 automatic task for neural models, and is trained end-to-end in a CNN [15] . 88
In recent years, a large number of high resolution digital Whole Slide Images 89 (WSI) of H&E stained tissue slides have been captured by pathologists [16] . 90
With an increasing amount of "big data", CNN has become an excellent 91 candidate for WSI processing tasks and it has been adapted by many studies 92 already for tasks like prediction of kidney function and segmentation 93 [17, 18] , breast cancer detection [19] , [43] , tumor prediction for 94 osteosarcoma [20] , colon cancer detection [21] and analysis of tumor-95 infiltrating lymphocytes [42] 229 breast) initially uploaded were removed because of compatibility and 147 readability issues. Additionally, tiles with more than 25% of background 148 were filtered out, as they are unlikely to contain informative features. This 149 process generated nearly 665,812 tiles for lung, 1,077,076 for kidney and 150 655,885 for breast. Before feeding the images into the network, we further 151 down-sampled the tiles to 299 × 299 pixels to make the network 152 comparable to Google's Inception V3, which requires 299 × 299 pixel inputs. 153 154
Data split into training, validation and test sets 155
For the three cancer types, the data was split into 70%, 15% and 15% into 156
training, validation and test datasets respectively ( Table 1) . To avoid 157 leakage, we ensured that all slides (and tiles) that came from the same 158 patient were included in the same dataset (training, validation, or test The first block uses a kernel size of 5, while the following blocks all used a 201 kernel size of 3. Furthermore, the first two blocks did not contain a pooling 202 layer, as we wanted to upsample the number of features before 203 downsampling with max pooling. 204 205
Hyper-parameter tuning 206
In our experiments, we found that tuning the dropout rate was very 207 important for model performance. With a dropout rate of p = 0.5, we were 208 only able to obtain an AUC of ∼0.857 on the validation set, while when we 209 decreased dropout to 0.1, we were able to consistently reach macro AUC 210 above 0.9. For aggregation, we used the average score across all the tiles 211 for each class which outperformed the proportion method. For nonlinearity, 212
we used leaky relu as it performed slightly better than relu only. For hyper-213 parameter tuning we performed a search similar to coordinate descent 214 algorithm, where we varied a particular hyper-parameter until we found the 215 best performing model, then moved on to optimize the next hyper-216 parameter. After several iterations to find a proper learning rate, we found 217 that the best learning rate was 0.001. As for the initialization, Xavier 
Tile aggregation 245
While the neural network was trained on a per-tile basis, the model must 246 perform classification on a per-slide basis. Thus, the per-tile scores from the 247 neural network were aggregated for the final prediction using two different 248 methods: (1) per-slide average score, where the average score across all 249 the tiles for each class is calculated, and (2) per-slide tile proportion, where 250 the class with the maximum score is assigned to each tile. The final score is 251 the proportion of tiles assigned to each class. 252 253
Model evaluation metrics 254
The Area Under the Curve (AUC) was used as the evaluation metric. AUC is 255 traditionally defined only for binary classification, but the lung and kidney 256 tasks had more than two classes. Therefore, first the AUC of individual 257 classes using a one-vs-all method were calculated. Then, the macro-average 258 (macro-AUC), which is the unweighted mean of the individual class AUCs 259
were calculated. Additionally we calculated the following metrics to further 260 evaluate the performance and the robustness of our results: Average of 261 Precision and Recall; Cohen's kappa (Eq.1), an indicator of agreement of 262 results commonly used for multi-class and imbalanced class problems; 263 Jaccard Coefficient (Eq.2), a measure of similarity and calculated by 264
Intersection over Union of predicted and true labels; Log-loss/cross entropy, 265 the negative log-likelihood of the true labels given a probabilistic classifier's 266 predictions [27] and it indicates much the predictions vary from the actual 267 labels. 268
Where is relative observed agreement and is the hypothetical probability 270 of chance agreement between the predictions and the actual labels. 271
Where X and Y are the prediction and actual label set. 275 276 277
Pan-cancer t-SNE visualization 278
For the pan-cancer analysis, we used our models' representation of each 279 image in later layers before reducing them into class probabilities, then 280 clustered those representations using Distributed Stochastic Neighbor 281 layer) weights which embeds the information in an array of size 5184 that is 283 later reduced to class probabilities to predict the label. We only extracted the 284 weight that belongs to tiles that were correctly classified by the model to 285 represent the given image, to increase the confidence interval of the 286 clustering. Then t-SNE was used to visualize these high dimensional 287
embedding (number of slides x 5184) in 2-dimensional space. To evaluate our deep learning architecture, we assessed its performance on 297 the lung dataset (LUAD, LUSC and normal lung from TCGA) and directly 298 compared to the state-of-the-art Inception V3 architecture previously used 299 for this task [37, 28] . When there was no time constrains, we were able to 300 obtain a macro AUC of 0.979 for the TCGA validation set at epoch 10 (when 301 the model fully converged) and an AUC of 0.957 for the TCGA test set on our 302 baseline lung cancer task, comparable to previously reported AUC achieved 303 by Inception V3 [28] . Detailed comparison of macro AUCs between Inception 304 and PathCNN as a function of the number of steps on validation set can be 305 seen in Figure 2a . The model does a nearly perfect job when the 306 classification task is only between tumor and normal lung tissue, with AUC of 307 0.99. Differentiating between the two types of lung cancer, LUAD and LUSC, 308
does not perform equally well, with individual one-vs-all AUC of 0.93 for 309 both classes ( Table 2) . This agrees with previously published results [27, 310 28] showing that tumors are visually distinct from normal tissue, while 311 cancer types or subtypes can be more challenging to visually differentiate. 312
The results from Yu et al. [7] also follow a similar pattern with a significant 313 difference in AUC between the two tasks. Examples of predictions of our 314 model and Inception V3 on selected lung adenocarcinoma (LUAD) and lung 315 squamous cell carcinoma (LUSC) slides are visualized using heat-maps 316 (Supplementary Figure 1) . 317 318 
Memory usage and speed comparison 323
Both models were trained on NVIDIA P100 GPU with 100GB memory. During 324 training, our model was much faster compared to inception (Figure 2b) : our 325 model required only 0.68 sec per iteration, whereas inception needed 1.8 326 sec per iteration. Furthermore, the average memory occupied at RAM was 327 lower than inception (3GB vs 4GB). Also, our model is much faster at test 328 time: 0.29 sec per tile compared to 0.044 sec with inception, i.e. more than 329 6 times faster. 330 331
Evaluation on independent cohorts 332
We then tested the performance of both models on independent datasets 333 collected the NYU Medical Center [28] . More specifically, we tested the 334 models on two types of specimens: surgical resections (98 frozen slides and 335 140 FFPE slides) and biopsies (102 slides 
Impact of training dataset size on performance 344
To measure how the amount of data used effect the model performances, 345
we performed a down-sampling analysis as follows: we trained the model on 346 reduced datasets by sampling slides (sampled at 1/9th, 1/3rd and 3/4 th after 347 ordering by name) and the full set (number of slides = 149, 446, 1000 and 348 1335) and tested on the same full test set from TCGA. Then we calculated 349 the average of AUCs obtained by testing on checkpoints after down-sampled 350 datasets validation sets performance converged during training. As 351 summarized in Figure 2c , we found that PathCNN generalized to the 352 external dataset much better for when trained on smaller datasets compared 353
to Inception (p = 0.0952, 0.0027, 0.0025, 2.6E-14). Furthermore, our 354 model had much faster convergence and showed better convergence-AUC 355 trade-off for the external datasets (Figure 2d) . 356
357

Impact of augmentation on performance 358
We found that the augmentation had a big effect on model performance. 359 AUC increased by ~0.02 (p<0.001) on the TCGA test data set 360 (Supplemental Figure 3) . Furthermore, interestingly we observed faster 361 overfitting when the training data was not augmented. 362
363
Performance on kidney and breast whole-slide images 364
We then retrained our model on all TCGA datasets: lung, kidney and breast. 365
Although optimized on the lung cancer dataset, our model transferred quite 366 well to the kidney and breast classification tasks. While we did retrain the 367 entire network (in contrast to a transfer learning approach), we found that 368 even without re-tuning the hyper-parameters, the AUCs were very high 369 (ROC curves are shown in Figure 3a-c) . In fact, we did not see the same 370 kind of drop in performance between the validation and tests sets, and they 371 were able to achieve a macro-AUC around 0.998 for kidney (in 12 epochs) 372 and 0.994 for breast (in 14 epochs) ( Table 3 and Table 4 ). 373 
382
Lastly, the performance of our algorithm is evaluated using various 383 statistical metrics: AUC, average of Precision and Recall, Cohen's kappa, 384
Jaccard Coefficient, and Log-loss. We found high degree of agreement and 385 similarity between the model class predictions and the actual classes as 386 indicated by the Cohen's kappa and Jaccard coefficient in Table 5 . Similar to 387 precision, recall and log-loss we see higher values with breast followed by 388 kidney and lung. 389 390 We then used PathCNN to simultaneously train for all the breast, kidney and 395 lung types/subtypes and corresponding normals (BRCA, KIRP, KIRC, KICH, 396 LUSC, LUAD and normal breast, kidney, lung). We obtained macro AUC of 397 0.987 on the validation set and 0.989 on the test set. ROC curves can be 398 seen in Figure 3a-d . We then performed dimensionality reduction on the 399 weights of the last fully-connected layer using t-Distributed Stochastic 400
Neighbor Embedding (t-SNE) [45] and visualized the result in two 401 dimensions (Figure 3e , each dot represents a whole-slide image). Overall, 402
we observed a clear separation by organ (breast, kidney or lung), and by 403 cancer type or normal within each organ (see blue, green and brown areas 404
in Figure 3e ). However, we also noticed smaller clusters of slides (clusters 405 A through H) outside these three large areas. We then asked a pathologist to 406 examine all these slides and annotate them. These slides and the 407 pathologist's annotations -grouped by slide type -are listed in Table 6 . 408
More specifically, area A represents a cluster of KIRP cases characterized by 409 intense basophilic staining. Area B is a single KIRC outlier (with a slide 410 composed of predominantly fat) and area C a KIRP outlier (that shows 411 significant frozen artifact). Area D is a normal kidney slide with interstitial 412 fibrosis, tubular atrophy and calcification-reactive features that can also be 413 seen among KIRP cases. Area E includes two normal breast outliers: these 414 slides were found to be overstained.. In area F, the pathologist found normal 415 also means it will be significantly faster at prediction time; aggregation and 437 prediction for a particular slide image took around 30 minutes. Limited 438 resources in a realistic health care setting means that this decrease in 439 diagnostic turnaround time could translate to positive real-world outcomes 440 for patients. We found that using data augmentation, tuning the learning 441 rate, reducing the drop-out rate, and increasing the depth were the most 442 important factors for achieving the best performance. With a simpler 443 architecture, we were able to reach comparable results to a very deep 444 network. With further hyper-parameter tuning and further software 445 optimization, better results and higher efficiency can be achieved. For lung 446 cancer, the individual class AUCs reflect how the network was better at 447 distinguishing between Solid Tissue Normal (non-neoplastic tissue) and the 448 two types of non-small cell lung cancer, with an AUC of around 0.999. On 449 the other hand, the network's performance is not as good when trying to 450 differentiate between the two different classes of cancer: Lung Squamous 451
Cell Carcinoma (TCGA-LUSC) and Lung Adenocarcinoma (TCGA-LUAD). 452
Another positive outcome from our work is that it generalizes well to kidney 453 and breast cancers. In fact, the AUC scores improved in comparison to the 454 ones achieved for lung: macro AUC of 0.997 and 0.996 on the test set 455 respectively. As with lung cancer, the model performed significantly better at 456 distinguishing non-neoplastic tissue from neoplastic tissue for both of these 457 cancer types. For breast cancer, there were only two possible classes: non-458 neoplastic and neoplastic tissue. Just as the case with lung cancer, we found 459 that our model can easily distinguish between these two classes even though 460 we did not further tune the hyper parameters specific to this data set. This 461
suggests that the framework we developed is well suited for the general task 462 of distinguishing neoplastic tissue from non-neoplastic tissue. For the kidney 463 cancer task, there were more neoplastic subtypes (3 compared to 2 for 464 lung). Nevertheless, we found that the model was almost perfectly able to 465 distinguish between them and achieved a macro AUC better than the lung 466 cancer task. On the test set, the individual class AUCs were 0.999, 0.994, 467 0.994, and 0.992 for Solid Tissue Normal, TCGA-KICH, TCGA-KIRC, TCGA-468 KIRP, respectively. This is likely due to the fact that these neoplastic 469 subtypes are more visually distinct than the lung cancer subtypes, and 470 therefore the task is easier overall. Another possible explanation could be 471 due to the difference in the available training data. After tiling, we had 472 around 1077k (925 slides) kidney cancer tiles compared to 666k (1928) lung 473 cancer tiles in their respective training sets, a 62% increase. This 474 phenomenon may be explained by the pre-processing step that removed any 475 tile with more than 25% background. The kidney tissue slides may be 476 denser with richer information. (1) In our experiments, we found that both ReLU and LeakyReLU worked well, 777 but using LeakyReLU resulted in slightly better performance. Therefore for 778 our final architecture, we used LeakyReLU with negative slope 0.01 as the 779 non-linearity. 780 781 Dropout 782
In our experiments, we found that tuning the dropout rate was very 783 important for model performance. When we first used the default dropout 784 rate of p = 0.5, we were only able to obtain an AUC of $\sim$0.857. We 785 realized that the dropout rate may be too high, especially as we were 786 applying dropout after every convolutional block. In comparison, the 787 Inception model only applies one layer of dropout after all of the blocks. 788
When we decreased dropout to 0.1, we were able to consistently reach 789 macro AUC above 0.9. Another explanation may also be due to the use of 790 batch normalization within each convolutional block. Both batch 791 normalization and dropout are regularization methods, so the use of batch 792 normalization reduces the need for dropout. In this case, the higher dropout 793 of $p = 0.5$ was causing our model to underfit. 794
Aggregation method 796
We tried both the average score and proportion of tiles methods for 797 aggregating the tiles, as described in the methodology section 3.7.1. We 798 found that the methods were comparable, though the average method 799 performed between 0.003 and 0.008 AUC better on the three datasets. 800
Intuitively, this makes sense: Assigning each tile a class based on the 801 maximum probability would treat a tile that is assigned a class with 99\% 802 probability the same as one with 60\% probability. Therefore, taking a 803 "majority vote" method per tile could potentially discard some useful 804 information for the prediction. 805 806
Other hyperparameters 807
We didn't run a full grid search on all the hyperparameters and options listed 808 in the methodology section. However, we performed a search similar to 809 coordinate descent algorithm where we varied a particular hyperparameter 810 until we found the best performing model, then moved on to optimize the 811 next hyperparameter. With this method, we were still able to draw some 812 insights into the effect of particular hyperparameters on model performance. 813
One of the first challenges we faced was finding the proper learning rate for 814 the model to learn. For learning rates smaller than 1e-5, the model tended 815
to get stuck with no major decreases in loss after one epoch. On the other 816 hand, when the learning rate was larger than 0.001, the loss function 817 showed a significant boost in performance. Without augmentation, our 840 model was only able to obtain macro AUC around 0.93 on the validation set 841 for the lung cancer task. With data augmentation, we were able to 842 consistently achieve macro AUCs above 0.96. In terms of the optimizers, 843 both Adam and RMSProp performed similarly. SGD, on the other hand, did 844 not perform as well. This is likely because SGD does not have a momentum-845 type mechanism to adaptively adjust the learning rate. Use of SGD can 846 require a lot more careful hyperparameter tuning than the adaptive methods 847 such as Adam and RMSProp. 
